EUVIMEDEUVIMED entdecken
Editorial

Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy

Yoichiro Tohi iD, Mikio Sugimoto iD

International Journal of Urology · 2026-11 · 33 (11)

DOI: 10.1111/iju.70693 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Urology, online erschienen am 29.10.2026. Verfasst von Yoichiro Tohi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.

ORCID-Profile: Yoichiro Tohi, Mikio Sugimoto

Zitieren

APA

Tohi, Y., & Sugimoto, M. (2026). Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy. International Journal of Urology, 33(11). https://doi.org/10.1111/iju.70693

Vancouver

Tohi Y, Sugimoto M. Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy. International Journal of Urology. 2026;33(11). doi:10.1111/iju.70693

BibTeX
@article{Tohi2026,
  author = {Tohi, Yoichiro and Sugimoto, Mikio},
  title = {Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {11},
  doi = {10.1111/iju.70693}
}
Kostenlos starten →